140 A prospective trial on the efficacy and tolerability of twice-daily dosing (TDD) versus once-daily dosing (ODD) amikacin in cystic fibrosis patients
| Autor: | S. Semykin, L.G. Dubovik, R.M. Sagatelyan, S.V. Polikarpova, L.A. Gracheva, S.S. Postnikov |
|---|---|
| Jazyk: | angličtina |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty business.industry medicine.disease Cystic fibrosis Tolerability Amikacin Prospective trial Internal medicine Pediatrics Perinatology and Child Health medicine Twice daily dosing Pediatrics Perinatology and Child Health Once daily dosing Intensive care medicine business medicine.drug |
| Zdroj: | Journal of Cystic Fibrosis. :S34 |
| ISSN: | 1569-1993 |
| DOI: | 10.1016/S1569-1993(07)60126-X |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|